Molina Healthcare, Inc. Q3 2025 Earnings Recap

Molina Healthcare's Q3 2025 results fell short of expectations, primarily due to heightened utilization costs in its Marketplace segment, resulting in a decreased full-year EPS guidance.

Key Takeaways

• Adjusted EPS for Q3 was $1.84 on premium revenue of $10.8 billion, leading to a revised annual EPS guidance of approximately $14, down from $19.
• Consolidated Medical Care Ratio (MCR) for Q3 stood at 92.6%, with notable pressures from higher medical costs, especially in the Marketplace segment at 95.6%.
• Medicaid continued to show resilience with an MCR of 92% and a pretax margin of 2.6%, despite rising medical cost trends driven by behavioral health and high-cost drugs.
• Q4 guidance projects $0.35 EPS, with Medicaid anticipated to contribute $3 per share amidst broader losses from Medicare and Marketplace.
• The company plans to build on its 2026 outlook through growth in existing markets and new Medicaid contracts, particularly in Georgia and Texas.